These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 3045108

  • 1. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 2. Panic disorder: the potential role of serotonin reuptake inhibitors.
    Sheehan DV, Zak JP, Miller JA, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109
    [Abstract] [Full Text] [Related]

  • 3. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS, Kim EJ, Roh D, Kim CH.
    Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmacologic treatment of child and adolescent obsessive compulsive disorder.
    Piacentini J, Jaffer M, Gitow A, Graae F, Davies SO, Del Bene D, Liebowitz M.
    Psychiatr Clin North Am; 1992 Mar; 15(1):87-107. PubMed ID: 1549550
    [Abstract] [Full Text] [Related]

  • 9. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K, Aoki M.
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [Abstract] [Full Text] [Related]

  • 11. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fluvoxamine as an antiobsessional agent.
    Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS.
    Psychopharmacol Bull; 1989 Aug; 25(1):31-5. PubMed ID: 2505302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New findings in obsessive-compulsive disorder.
    Kim SW, Dysken MW.
    Minn Med; 1989 Feb; 72(2):91-3, 110. PubMed ID: 2651867
    [Abstract] [Full Text] [Related]

  • 18. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [Abstract] [Full Text] [Related]

  • 19. [Psychobiology of compulsive disease].
    Lesch KP.
    Fortschr Neurol Psychiatr; 1991 Oct; 59(10):404-12. PubMed ID: 1761269
    [Abstract] [Full Text] [Related]

  • 20. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
    Greist JH.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.